pharmaphorum

OCTOBER 6, 2022

Fresh with a new brand identity, the France-headquartered pharma group has pledged to grow its oncology sales from its current objective of €1 billion in 2025 to €3 billion in 2030, continuing a diversification of its business from its traditional focus on cardiovascular diseases. billion and $1.8 billion, respectively, five years later.

Generic Medicine 98

Generic Medicine Chemotherapy 98

Hospital Pharmacy Europe

AUGUST 13, 2024

The first version of a list of critical medicines was published in 2023, with the aim to prevent disruption and help track EU manufacturing capacity and ensure the security of supply and availability of critical medicines at the EU level. This platform is expected to be operational by early 2025.

Hospitals 59

Hospitals Generic Medicine Communication 59

The Checkup by Singlecare

OCTOBER 8, 2024

Generic drugs contain the same active ingredients found in their brand-name counterparts. A Xigduo XR generic version may become available in 2025 , when the brand-name patent is set to expire. Sometimes, there are generic medicines or other treatment plans that can effectively manage your condition at a lower cost.

Insurance 52

Insurance Dosage Generic Medicine FDA 52

The Checkup by Singlecare

FEBRUARY 10, 2025

Additionally, several other companies have tentative FDA approvals, meaning that their generic versions have met the requirements for FDA approval but cannot yet be marketed in the United States due to patent issues. As of January 2025, only the Prasco version of dapagliflozin is available in pharmacies.

Dosage 52

Dosage Labelling Hospitals FDA 52

European Pharmaceutical Review

FEBRUARY 3, 2025

EMAs human medicines committee (CHMP) recommended eight medicines for EU marketing authorisation at its January 2025 meeting. Additionally, the CHMP recommended the generic medicine Eltrombopag Accord (eltrombopag) to treat primary immune thrombocytopenia and thrombocytopenia associated with chronic hepatitis C.

Generic Medicine 52

Generic Medicine Vaccines Chemotherapy Immunization 52

European Pharmaceutical Review

FEBRUARY 20, 2025

The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. 2 Introducing tariffs on pharmaceutical imports could lead to significant disruptions, particularly for generic medicines , which often rely on lower-cost API sourcing.

Generic Medicine 20

Generic Medicine Hospitals Patient Care Vaccines 20